Logo
    Search

    biopharma

    Explore " biopharma" with insightful episodes like "a16z Bio + Health #8: How to Innovate within Biopharma with Jay Bradner" and "When Bad Policy = Bad Business Models = Bad Public Health" from podcasts like ""a16z Live" and "a16z Podcast"" and more!

    Episodes (2)

    a16z Bio + Health #8: How to Innovate within Biopharma with Jay Bradner

    a16z Bio + Health #8: How to Innovate within Biopharma with Jay Bradner
    On this episode of the a16z Bio Clubhouse Show, a16z general partners Vineeta Agarwala, Jorge Conde, Julie Yoo, and Vijay Pande talk to guest Jay Bradner, President of the Novartis Institute of Biomedical Research (NIBR). The conversation covers the challenges of translating basic research into a clinical application, the state of innovation in therapeutics, and the transition from drug hunting to drug farming.

    When Bad Policy = Bad Business Models = Bad Public Health

    When Bad Policy = Bad Business Models = Bad Public Health

    with @JorgeCondeBio, @julesyoo, and @omnivorousread

    In some ways, the coronavirus feels like it came out of nowhere—a kind of Black Swan event. But at the same time, it's been exposing a lot of the fundamental flaws in our healthcare system that now feel like a perfect storm coming together... and have hurt our ability to address the problem that we should really have seen coming.

    In this episode, a16z General Partners Jorge Conde and Julie Yoo talk with Hanne Tidnam about some of those big forces and dynamics in the healthcare system, at the intersection of business, policy, and public health: how in healthcare like perhaps nowhere else, broken policy can lead to broken business models that, in the wrong circumstances, can then lead major failures in public health like the one we’re seeing today; where we’ve seen this before, in the markets of vaccines, antibiotics, and diagnostics; and what should be different next time, so that when a new pandemic hits we aren’t facing another perfect storm.